The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

The struggle of funding winter brought with it sanity in valuations and forced startups to cut their expenses to chart a profitable growth. This trend continued in FY24 as well Of the 98 startups ...